Core First Bank & Trust Jazz Pharmaceuticals PLC Transaction History
Core First Bank & Trust
- $167 Million
- Q4 2024
A detailed history of Core First Bank & Trust transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Core First Bank & Trust holds 225 shares of JAZZ stock, worth $31,425. This represents 0.02% of its overall portfolio holdings.
Number of Shares
225
Previous 225
-0.0%
Holding current value
$31,425
Previous $25,000
8.0%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$858 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$843 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$354 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$309 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$284 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.75B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...